SCHEMBL25848147

SCHEMBL25848147

C=CC(=O)OCC(C)COc1ccc2cc(-c3ccccc3CC)c(=O)oc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.46
NPC1 O15118 7/20 0.46
KDM4E B2RXH2 6/20 0.44
ALDH1A1 P00352 6/20 0.44
GAA P10253 5/20 0.44
HPGD P15428 5/20 0.44
GLA P06280 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
MAPT P10636 3/20 0.44
MAPK1 P28482 2/20 0.44
PKM P14618 1/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KLK7 P49862 1/20 0.44
HSD17B10 Q99714 2/20 0.43
RECQL P46063 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAOB P27338 2/20 0.41
MAOA P21397 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25848143 0.88 NPC1 (0.60) RAB9ANPC1KDM4EALDH1A1GAA
SCHEMBL22624936 0.88 RAB9A (0.43) RAB9ANPC1KDM4EALDH1A1GAA
SCHEMBL25848149 0.87 RAB9A (0.48) RAB9ANPC1KDM4EALDH1A1GAA
SCHEMBL22624923 0.86 RAB9A (0.42) RAB9ANPC1KDM4EALDH1A1GAA
SCHEMBL25848150 0.85 THRB (0.42) RAB9ANPC1KDM4EALDH1A1GAA
SCHEMBL25848177 0.84 RAB9A (0.46) RAB9ANPC1KDM4EALDH1A1GAA
SCHEMBL25848163 0.83 NPC1 (0.46) RAB9ANPC1KDM4EALDH1A1GAA
SCHEMBL22624938 0.81 RAB9A (0.43) RAB9ANPC1KDM4EALDH1A1GAA
SCHEMBL22590752 0.81 RAB9A (0.52) RAB9ANPC1KDM4EALDH1A1GAA
SCHEMBL22625066 0.81 RAB9A (0.43) RAB9ANPC1KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 RAB9A 1916/4885NPC1 1051/4885KDM4E 4579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.